Christian Weyer

Ex-CEO of Fate Therapeutics

Education

M.D. from the University of Ulm, Germany.

Field of Expertise

Healthcare & Life Sciences - Medicine

Born

June 15, 1965 - 59 years ago

Economy Sector

Healthcare

Tenure

3 years 2 months (Sep 2012 - Nov 2015)

Previous Experience

Served as Chief Medical Officer at Amylin Pharmaceuticals.

Christian Weyer is a former CEO of Fate Therapeutics, a company focused on developing cellular therapies. He has a rich background in medicine and research, holding an M.D. from UCLA and significant leadership experience. Before joining Fate, he spent over a decade with Amylin Pharmaceuticals, where he ended as Senior Vice President of Research and Development. He was involved in many key projects, helping the company advance its drug pipeline.

Year

2015

Total Compensation

$366.03K

Salary

$366.03K

Board Justification

The company aims to align CEO compensation with performance metrics related to corporate objectives, including advancement of clinical and preclinical programs and corporate development initiatives.

Bonus

$0.00

Board Justification

No non-equity incentive plan compensation was reported for 2015 as Dr. Weyer voluntarily resigned before the end of the year.

Other

$0.00

Board Justification

No other compensation was reported for 2015.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards were reported as vested for 2015.

Performance Metrics

The performance metrics for determining compensation included objectives related to the advancement of clinical and preclinical programs and achievement of corporate development and financing initiatives.

J. Scott Wolchko

Ex-CEO of Fate Therapeutics

December 2015 - January 2025